Dr. Christopher Haskell leads Bayer’s U.S. Science Hub, based in the company’s U.S. Innovation Center located at Mission Bay, San Francisco. Haskell and his group support Bayer’s Global Drug Discovery through developing and managing partnerships with U.S. academic research institutions and emerging life science firms.  Haskell is also responsible for the development of the CoLaborator, Bayer’s biotech incubator space adjacent to the company’s U.S. Innovation Center.

In addition, Haskell is chair of the California Life Sciences Institute and a board member of the California Life Sciences Association.
 
Haskell completed his graduate studies at the University of California, Davis and a postdoctoral fellowship at The Gladstone Institute in San Francisco.